Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient
article
OA: closed
CC0
⤵ 11 in-corpus citations
AI-generated summary
A levonorgestrel-releasing intrauterine system effectively treated menorrhagia, dysmenorrhea, and reduced uterine and myoma size in a renal transplant patient with uterine myomas.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The levonorgestrel-releasing intrauterine system (LNG-IUS) has been used in the treatment of both idiopathic menorrhagia and adenomyosis. An electronic search of the on-line medical literature revealed no reports of its use for menorrhagia secondary to uterine myomas. Presented here is the successful treatment of uterine myomas with menorrhagia in a woman with a renal transplant. There was a significant reduction in menorrhagia, dysmenorrhea, and uterine and myoma size with the use of the LNG-IUS. We believe that this system provides an alternative to conventional hysterectomy and gonadotrophin-releasing hormonal analog medical treatment for uterine myomas, with a possibly inhibitory effect on myoma growth.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (12)
- A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia via openalex
- mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system via openalex
- Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device via openalex
- W2070761958 via openalex
- W2119767373 via openalex
- W2273333468 via openalex
- W2293013867 via openalex
- W4231243180 via openalex
- W1997430923 via openalex
- W4242280866 via openalex
- W2014994159 via openalex
- W2060059789 via openalex
Cited by (9)
- Surgical Management Options for Patients with Infertility and Endometriosis 2010
- Contraception and gynaecological care 2009
- Efeitos do sistema intra-uterino de Levonorgestrel sobre marcadores de risco cardiovascular de pacientes com endometriose: estudo comparativo com o análogo do GnRH 2009
- Levonorgestrelį išskiriančios gimdos spiralės vartojimas ginekologijoje 2009
- Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications 2009
- Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—A systematic enquiry and overview 2005
- Hysteroscopic Endometrial Ablation as a Treatment for Abnormal Uterine Bleeding in Patients with Renal Transplants 2004
- Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding 2004
- Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: Actualities and ambiguities 2002
Source provenance
- europepmc
- last seen: 2026-09-15T06:16:59.523076+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:10:24.024533+00:00
- unpaywall
- last seen: 2026-09-15T06:33:26.365676+00:00
License: CC0
· commercial use OK